Navigation Links
SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
Date:10/14/2008

New SYNTAX Score shows similar safety and efficacy outcomes for two thirds

of study's patients

NATICK, Mass. and WASHINGTON, Oct. 14 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced 12-month left main and three-vessel disease subset data from its landmark SYNTAX trial comparing percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System to contemporary coronary artery bypass graft (CABG) surgery. The results reinforced previously announced data demonstrating no overall statistically significant differences between PCI and CABG in rates of death or myocardial infarction (MI). The Company also presented an analysis of the data based on the SYNTAX Score, a new tool that seeks to provide guidance to physicians on optimal treatment options for this high-risk group of patients, showing similar safety and efficacy outcomes for two thirds of SYNTAX randomized patients. The Company made the announcements at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C.

The SYNTAX trial is the first large scale randomized, controlled clinical trial comparing PCI using drug-eluting stents (DES) to CABG in patients with left main disease and three-vessel disease. These patient groups are typically treated with CABG and represent a population with far more complex anatomy and advanced disease than those studied in prior DES clinical trials. The goal of the trial is to expand the body of knowledge of PCI use and help inform physicians and patients on appropriate treatment options for the sickest patients.

"The data announced today will prov
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
2. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
3. MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy
4. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
5. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
6. Abbotts XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
7. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
8. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
9. Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
10. New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
11. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)...  In anticipation of the upcoming MEDevice San Diego ... the first time. Industry Overview: Medtech & Life Sciences ... snapshot of San Diego,s critical involvement ... latest employment statistics to current venture capital investment trends, the ... such a vital part of the global medical device ...
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate ... The Gambia and Mali ... safety trials of potential vaccines aimed at preventing the disease that ... West Africa . Human trials of ... Health (NIH) and GlaxoSmithKline, are to be accelerated with funding from ...
(Date:8/28/2014)... 2014 According to a new ... (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) - ... 2014 - 2020" the global radiofrequency identification (RFID) market ... is expected to grow at a CAGR of 13.9% ... of USD 5.3 billion in 2020. Browse ...
Breaking Medicine Technology:New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5
... Md., Sept. 15 Pre-mixed insulin,analogues, a modified ... than long-acting analogues for controlling high blood sugar,levels ... according to a report,funded by the Agency for ... of Health and Human Services., Conventional pre-mixed ...
... Results inconclusive, as primary outcome measure not statistically ... by improvement in placebo group, ... -- Overall safety and tolerability profile comparable to placebo, ... -- Next steps include further analysis of full dataset ...
Cached Medicine Technology:Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 4
(Date:8/29/2014)... New York (PRWEB) August 29, 2014 ... of Micro-Needling services in their Latham aesthetic office. ... technology, is one of the first surgeons in the ... . The innovative technique is faster and safer ... , Micro-Needling is a noninvasive procedure , ...
(Date:8/29/2014)... Aug. 29, 2014 (HealthDay News) -- Researchers have discovered ... their brains. Dyslexia -- the most commonly diagnosed ... with reading and writing. Previous research showed that ... most of those studies focused only on a small ... functional MRI to analyze how multiple brain regions use ...
(Date:8/29/2014)... August 29, 2014 Parker Waichman LLP, ... to protecting the rights of victims who have been ... (DEA) has announced new regulations for all hydrocodone combination ... (RAPS) report dated August 21, 2014, the DEA ... drugs under federal law. , The long-awaited announcement ...
(Date:8/29/2014)... Hastings and Hastings, a Phoenix personal injury ... many years is pleased to report having saved a ... convenient locations throughout the Valley, Hastings and Hastings offers ... attorney. In addition, experienced personal injury lawyers can arrange ... dedication and service is indicative of a law firm ...
(Date:8/29/2014)... August 29, 2014 Many Americans are ... keep diabetes type 2 at bay, patients should consider ... make the necessary lifestyle changes. While some diabetes risk ... history, advanced age, or belonging to certain ethnic groups, ... – their weight. Carrying extra pounds, especially in the ...
Breaking Medicine News(10 mins):Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $20,900 On A Settlement Of $190,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $20,900 On A Settlement Of $190,000 3Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 3
... Reinberg HealthDay Reporter , TUESDAY, Oct. 5 ... scans for injury-related emergency room visits in the United ... "There has been a dramatic increase in the likelihood ... to emergency departments for injury-related conditions without a corresponding ...
... DATE: Dana-Farber/Children,s Hospital Cancer Care is hosting the 42nd Congress ... pediatric oncology meeting in the world, SIOP is returning to ... Dates:, Thursday, Oct. 21, through Sunday, Oct. 24, ... p.m., Thursday through Saturday, and 8 a.m. to 3 p.m. ...
... Serena Gordon HealthDay Reporter , TUESDAY, Oct. 5 ... they not only protect themselves throughout their pregnancy but may ... few months of life. A study published online ... Medicine found that when women were vaccinated in the ...
... GRAND RAPIDS, MICH., Oct. 5, 2010 Only about ... and vegetable intake recommendations, which means they are ... health benefits (1). Along with vitamins, minerals and fiber, ... carotenoids, which research suggests help support women,s health including ...
... , TUESDAY, Oct. 5 (HealthDay News) -- Sophisticated brain ... patients with mild cognitive impairment are likely to progress ... combination of specialized MRI scans and an artificial intelligence ... were able to predict which patients had mild cognitive ...
... the microscope in a major new study, led by an ... its potential advantages and disadvantages. The study, which is ... examine the motives people have for travelling across national boundaries ... hip or joint replacement, cosmetic surgery and fertility treatment. ...
Cached Medicine News:Health News:MRI, CT Scans for ER Patients Triple Over Decade 2Health News:MRI, CT Scans for ER Patients Triple Over Decade 3Health News:Boston, Oct. 21-24: Largest international pediatric oncology conference 2Health News:Mom's Flu Shot May Protect Baby After Birth 2Health News:Mom's Flu Shot May Protect Baby After Birth 3Health News:Shortfalls in carotenoid intake may impact women's health 2Health News:Shortfalls in carotenoid intake may impact women's health 3Health News:Shortfalls in carotenoid intake may impact women's health 4Health News:Computer-Aided MRI Might Help Predict Alzheimer's 2Health News:Computer-Aided MRI Might Help Predict Alzheimer's 3Health News:Traveling for treatment: The case for and against 2
The Perfecta IMC Stems, manufactured from forged cobalt- chrome, are specifically designed for cemented femoral stem arthroplasty....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Simple straight stem design for the low-demand patient....
Dual offset femoral stems, hip stems that provide unique and competitive features....
Medicine Products: